A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
Clinical trial NCT02563054 · COMPLETED
Trial details
- NCT number
- NCT02563054
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2010-08-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.